Skip to main content

Table 1 Association of rare coding variants with breast cancer, for the 113 DNA repair genes sequenced in the GENESIS population [20]

From: Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation

Gene

Any variant

Control carriers

Case carriers

ORa (95% CI)

P value

Groupb

BABAM1/MERIT40

4

2

0.5 (0.1, 2.8)

0.43

Low

BACH1

22

21

0.8 (0.4, 1.5)

0.55

Low

BRCC3/BRCC36

3

1

0.3 (0.0, 3.2)

0.34

Low

BRE

11

7

0.6 (0.2, 1.6)

0.35

Low

CDH1

14

11

0.8 (0.4, 1.7)

0.54

Low

CDKN1A

13

11

0.8 (0.4, 1.9)

0.66

Low

COBRA1

6

4

0.7 (0.2, 2.4)

0.55

Low

DLG1

25

15

0.6 (0.3, 1.2)

0.12

Low

ESR1

10

6

0.6 (0.2, 1.5)

0.26

Low

EXO1

45

37

0.8 (0.5, 1.3)

0.41

Low

FAM175A/ABRAXAS

7

5

0.7 (0.2, 2.3)

0.56

Low

FANCA

19

15

0.8 (0.4, 1.6)

0.53

Low

FANCD2

20

15

0.7 (0.4, 1.4)

0.33

Low

FANCF

6

5

0.8 (0.3, 2.8)

0.77

Low

FANCG

6

4

0.7 (0.2, 2.4)

0.55

Low

FANCI

22

13

0.6 (0.3, 1.2)

0.13

Low

IRS2

13

9

0.7 (0.3, 1.5)

0.33

Low

KIAA1967

22

17

0.8 (0.4, 1.5)

0.41

Low

LIG4

15

13

0.7 (0.3, 1.6)

0.46

Low

MLH3

21

10

0.5 (0.2, 1.0)

0.06

Low

MUS81

10

7

0.6 (0.2, 1.6)

0.30

Low

MYC

2

2

0.8 (0.1, 5.5)

0.78

Low

NAT1

3

1

0.4 (0.0, 3.4)

0.37

Low

PMS2

22

16

0.7 (0.3, 1.3)

0.24

Low

POLH

13

5

0.4 (0.1, 1.1)

0.07

Low

POLQ

43

36

0.8 (0.5, 1.2)

0.43

Low

PRKAA2

8

3

0.4 (0.1, 1.5)

0.16

Low

RAD51D/RAD51L3

9

4

0.4 (0.1, 1.4)

0.17

Low

RAD54L

21

12

0.6 (0.3, 1.2)

0.14

Low

RTEL1

20

8

0.4 (0.2, 0.9)

0.03

Low

TIMELESS

28

23

0.8 (0.5, 1.4)

0.44

Low

TP53BP1

27

21

0.8 (0.5, 1.5)

0.51

Low

TP63

6

3

0.5 (0.1, 2.0)

0.33

Low

TTI2

9

7

0.8 (0.3, 2.2)

0.67

Low

WDR48

15

10

0.7 (0.3, 1.5)

0.36

Low

XRCC1

31

21

0.7 (0.4, 1.2)

0.14

Low

APEX1

10

10

1.0 (0.4, 2.4)

0.98

No effect

AR

32

31

1.0 (0.6, 1.6)

0.94

No effect

ATR

30

29

1.0 (0.6, 1.6)

0.92

No effect

BAP1

4

4

1.0 (0.3, 4.0)

1.00

No effect

BLM

35

31

0.9 (0.5, 1.4)

0.59

No effect

CDC27

12

12

1.0 (0.5, 2.3)

0.98

No effect

CDKN2A

3

3

1.0 (0.2, 4.9)

0.99

No effect

EIF4G1

26

29

1.1 (0.7, 1.9)

0.67

No effect

EP300

21

18

0.9 (0.5, 1.6)

0.66

No effect

ERCC6

47

53

1.1 (0.8, 1.7)

0.55

No effect

FANCB

9

9

0.9 (0.4, 2.4)

0.87

No effect

FANCC

11

10

0.9 (0.4, 2.2)

0.87

No effect

FANCE

11

10

0.9 (0.4, 2.2)

0.86

No effect

FANCL

9

10

1.1 (0.4, 2.8)

0.84

No effect

FLNA

25

24

1.0 (0.6, 1.7)

0.94

No effect

MAGI3

26

28

1.1 (0.6, 1.8)

0.82

No effect

MAST2

46

50

1.1 (0.7, 1.7)

0.66

No effect

MCM4

25

29

1.1 (0.7, 1.9)

0.70

No effect

MCPH1

27

28

1.0 (0.6, 1.8)

0.92

No effect

MDC1

24

22

0.9 (0.5, 1.7)

0.81

No effect

MSH2

18

17

0.9 (0.5, 1.8)

0.76

No effect

MSH6

16

16

0.9 (0.5, 1.9)

0.86

No effect

NBN

26

27

1.0 (0.6, 1.8)

0.87

No effect

PHLPP2

32

34

1.0 (0.6, 1.7)

0.97

No effect

POLK

22

22

1.0 (0.5, 1.8)

0.99

No effect

RAD51B/REC2/RAD51L1

6

5

0.9 (0.3, 2.8)

0.80

No effect

RECQL4

49

55

1.1 (0.8, 1.7)

0.59

No effect

RINT1

8

8

1.0 (0.4, 2.8)

0.95

No effect

SETX

25

24

1.0 (0.6, 1.7)

0.91

No effect

TELO2

17

18

1.1 (0.5, 2.1)

0.89

No effect

XRCC2

7

6

0.9 (0.3, 2.7)

0.84

No effect

APLF

7

11

1.5 (0.6, 3.9)

0.40

High

ATM

40

77

1.9 (1.3, 2.9)

0.001

High

BARD1

7

9

1.3 (0.5, 3.6)

0.59

High

BRIP1/FANCJ

16

25

1.5 (0.8, 2.8)

0.25

High

CHEK1

4

6

1.2 (0.3, 4.5)

0.75

High

CHEK2

22

62

3.0 (1.9, 5.0)

0.00001

High

CHGB

9

11

1.2 (0.5, 3.0)

0.65

High

DCLRE1C

9

14

1.6 (0.7, 3.7)

0.28

High

DGKZ

33

38

1.2 (0.7, 1.9)

0.52

High

ERCC2

17

27

1.6 (0.9, 3.0)

0.13

High

EYA3

6

7

1.2 (0.4, 3.5)

0.77

High

FANCM

23

38

1.7 (1.0, 2.8)

0.06

High

FEN1

6

7

1.2 (0.4, 3.6)

0.74

High

FOXO1

6

7

1.8 (0.5, 6.0)

0.38

High

FOXO3

0

8

-

-

High

FOXO4

0

4

-

-

High

MAST1

8

17

2.2 (0.9, 5.1)

0.07

High

MCM7

10

18

1.8 (0.8, 4.0)

0.13

High

MLH1

15

19

1.3 (0.6, 2.5)

0.52

High

MRE11A

12

14

1.2 (0.6, 2.6)

0.64

High

MSH3

25

30

1.2 (0.7, 2.1)

0.49

High

NTHL1

18

22

1.2 (0.6, 2.2)

0.65

High

NUMA1

36

51

1.4 (0.9, 2.2)

0.12

High

PALB2

9

30

3.5 (1.7, 7.5)

0.001

High

PIK3R1

1

4

4.3 (0.5, 38.3)

0.20

High

PMS1

6

10

1.5 (0.6, 4.3)

0.41

High

PPM1D

4

6

1.5 (0.4, 5.4)

0.53

High

PTEN

0

4

-

-

High

RAD50

30

37

1.2 (0.7, 2.0)

0.44

High

RAD51C

7

10

1.5 (0.6, 4.0)

0.41

High

RAD9B

4

6

1.5 (0.4, 5.2)

0.55

High

RECQL5

20

29

1.5 (0.9, 2.7)

0.14

High

REV3L

31

39

1.3 (0.8, 2.1)

0.30

High

RNF168

13

16

1.2 (0.6, 2.6)

0.59

High

RPA1

9

14

1.5 (0.7, 3.6)

0.32

High

SLX4/FANCP

36

44

1.2 (0.8, 1.9)

0.38

High

STK11

1

2

2.1 (0.2, 22.9)

0.55

High

TGFB1

5

9

1.6 (0.5, 4.9)

0.38

High

TOP3A

22

31

1.4 (0.8, 2.5)

0.23

High

TP53

3

6

2.0 (0.5, 8.0)

0.34

High

TSC2

45

56

1.3 (0.9, 1.9)

0.23

High

TTI1

26

30

1.2 (0.7, 2.0)

0.57

High

UIMC1/RAP80

12

15

1.2 (0.6, 2.7)

0.58

High

USP8

9

16

1.7 (0.7, 3.8)

0.23

High

WRN

47

59

1.3 (0.9, 1.9)

0.23

High

XRCC3

4

7

1.8 (0.5, 6.2)

0.36

High

  1. Abbreviations: OR (95%CI) odds ratio (95% confidence interval)
  2. aReference group: non-carrier of a variant in the tested gene
  3. bGroup “Low”: OR <0.9; Group “No Effect”: 0.9≤ OR ≤1.1; Group “High”: OR >1.1